The Validity of the Use of Neuroprotective Therapy in the Treatment of Hypertension in Patients with Aanamnesis to Radiation
Abstract
Key words: Arterial hypertension, cognitive abnormality, neuroprotection therapy, kortexin, liquidators of the Chernobyl nuclear disaster.
Annotation: The results of the study efficacy of neuroprotection in the complex treatment of arterial hypertension (AH) and the liquidators of the Chernobyl accident (LPA), the duration of conservation of the results depending on the course dose and frequency of application. To obtain a stable (12 months) result in the improvement of cognitive disorders, reducing blood pressure to great effect when using 2-rate 20-day treatment cortexin every 6 months.
Volltext:
PDF (Russian)Literaturhinweise
Barkhatov DYu, Glotova NA, Konovalov RN et al. Neuroprotection efficiency in patients with chronic cerebrovascular diseases: International neurology journal, 2011, № 7(45); 37-42.
Batysheva TT, Biletsky PS, Bojko AN et al. Chronic brain circulation insufficiency and neuroprotection, novelty in diagnostics. In. Neuroprotection at acute and chronic brain circulation insufficiency. St-Petersburg: Nauka (Science), 2007; 200.
Cacciatore F, Abete P, Ferrara N, et al. The role of blood pressure in cognitive impairment in an elderly population: J. Hypertens, 2002, № 15; 135-142.
de la Torre JC. Alzheimer Disease as a Vascular Disorder: Nosological Evidence: J. Stroke, 2002, № 33; 1152-1162.
Efremushkin GG, Podsonnaya IV. Arterial hypertension and dyscirculatory encephalopathy - what is primary?: Cardiosomatics, 2011, № 4; 28-34.
Efremushkin GG, Podsonnaya IV. Sequence of formation of the discirculatory encephalopathy and the arterial hypertension in the liquidators of the Chernobyl power plant accident and in the irradiater population. The 2nd international conference on Hart & Brain. Paris, France, 2014, 219.
Elias PK, Elias MF, Robbins MA. et al. Blood Pressure –Related Cognitive Decline. Does Age Make a Difference?: J. Hypertension, 2004, № 44; 631-636.
GolovkinVI. Cortexin for epilepsy treatment. In. Cortexin. 5-year experience of Russian neurology. Moscow: Nauka (Science), 2006; 224.
Granstrem OK, Sorokina EG, Salykina MA et al. Cortexin: neuroprotection at the molecular level: Neuroimmunology, 2010, № 8(1-2); 34-40.
Hakamada R, Uehara Y, Haebara T. et al. The relationship between changes in normal-range systolic blood pressure and cognitive function in middle-aged healthy women: J.Hypertens Res., 2002, № 25; 565-569.
Harrington F, Saxby BK, McKeith IG. et al. Cognitive performance in hypertensive and normotensive older subjects: J. Hypertension, 2000, № 36; 1079-1085.
Konoplyova OP, Sholomov II, Volzhenin VE et al. Brain perfusion and neuroprotective therapy at hypertension disease. In. Polenov readings: materials of Russian scientific conference – Collected articles. St-Petersburg, 2006; 134-135.
Konradi AO. Antihypertensive therapy as prophylaxis and correction (remodeling) of cognitive disorders: Arterial hypertension, 2005, № 3; 160-163.
Kuznetsov VV. Cortexin as the therapy of cerebral pathology: International neurology journal, 2007, № 4(14); 113-116.
Madzhidova EN, Usmanova DD. Cortexin efficiency in correction of cognitive disorders in patients with chronic brain ischemia: International neurology journal, 2012, № 4(50); 48-50.
Melnikova EV, Pozdnyakov AV, Skoromets AA. Neuroprotection (neuropatronage) at chronic insufficiency of brain blood circulation. Complex case (patient), 2009, № 3; 16-20.
Osipov EV, Gelpey MA, Batyushin MM et al. The study of marked cognitive disorders in patients with arterial hypertension: International Journal of applied and fundamental researches, 2005(2), № 8; 254-258.
Poverennova IE, Sevastyanova EV. The peculiarities of cognitive disorders at arterial hypertension: Saratov. Medical Journal, 2008, № 4(January-March), 1(19); 88-92.
Starchina YuA, Parfenov VA, Chazova IE, et al. Cognitive disorders in patients with arterial hypertension: Neurology and psychiatry journal (named after S.S. Korsakov), 2008, № 108(4); 19-23.
Studenikin VM, Pak LA, Tursunkhuzhaeva SSh et. al. Peptide bioregulators and their application: from neonatology to gerontology: Attending physician: Clinical pharmacology, 2010, № 6; 72-75.